Literature DB >> 8120280

Effect of experimental rhinovirus 39 infection on the nasal response to histamine and cold air challenges in allergic and nonallergic subjects.

W J Doyle1, D P Skoner, J T Seroky, P Fireman, J M Gwaltney.   

Abstract

To determine whether a viral upper respiratory tract infection can alter the responsiveness of the nasal mucosa, paired intranasal histamine and cold air challenge sessions were performed before and after (8 to 13 days) experimental rhinovirus infection in 18 nonallergic subjects and 20 subjects with seasonal allergic rhinitis. The nasal response to the challenges was measured as symptom scores for rhinorrhea and congestion, counts for sneezing, weight for expelled secretions, and inspiratory conductance for nasal patency. For both sessions, a greater response was observed in allergic subjects for sneezing, symptoms of rhinorrhea and congestion, secretion weights provoked by histamine challenge, and secretion weights provoked by cold air challenge when compared with the nonallergic subjects. A comparison of the responses to the paired challenge sessions showed greater responses for sneezing, secretion weight and rhinorrhea to histamine and for secretion weight to cold air challenges performed after rhinovirus infection. No differences were observed between allergic and nonallergic subjects with respect to the degree of enhanced responsiveness secondary to viral infection. These results document an increased responsiveness of the nose to these stimuli during the postsymptomatic period of a rhinovirus infection in both allergic and nonallergic subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120280     DOI: 10.1016/0091-6749(94)90364-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects.

Authors:  R M Wadowsky; S M Mietzner; D P Skoner; W J Doyle; P Fireman
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

2.  Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness.

Authors:  H Hakonarson; N Maskeri; C Carter; R L Hodinka; D Campbell; M M Grunstein
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

Review 3.  The Role of Environmental Risk Factors on the Development of Childhood Allergic Rhinitis.

Authors:  Allison C Wu; Amber Dahlin; Alberta L Wang
Journal:  Children (Basel)       Date:  2021-08-17

Review 4.  The common cold and asthma.

Authors:  N Mygind; J M Gwaltney; B Winther; J O Hendley
Journal:  Allergy       Date:  1999       Impact factor: 13.146

Review 5.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

6.  Variant effect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold.

Authors:  P S Muether; J M Gwaltney
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

Review 7.  Rhinitis Subtypes, Endotypes, and Definitions.

Authors:  Nikolaos G Papadopoulos; George V Guibas
Journal:  Immunol Allergy Clin North Am       Date:  2016-02-28       Impact factor: 3.479

Review 8.  The common cold: current therapy and natural history.

Authors:  S L Spector
Journal:  J Allergy Clin Immunol       Date:  1995-05       Impact factor: 10.793

9.  Potential benefits of ibuprofen in the treatment of viral respiratory infections.

Authors:  Birgit Winther; Niels Mygind
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.